Advertisement

International Journal of Hematology

, Volume 79, Issue 3, pp 216–220 | Cite as

Chronic graft-versus-host disease: Clinical features and grading systems

  • Gérard Socié
Progress in hematology

Abstract

Chronic graft-versus-host disease (GVHD) is the prime cause of transplantation-related mortality late after marrow grafting and contributes directly or indirectly to most nonmalignant complications. The main clinical symptoms and diagnostic problems of chronic GVHD are summarized here.A major issue in treating chronic GVHD is to assess disease severity.A critical review of published grading systems failed to demonstrate that any system is better than the others. Prospective validation of the Johns Hopkins grading scale is timely and warranted.

Key words

Chronic GVHD Late complications Bone marrow transplantation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lee SJ, Klein JP, Barrett AJ, et al. Severity of chronic graft-versushost disease: association with treatment-related mortality and relapse. Blood. 2002;100:406–414.CrossRefPubMedGoogle Scholar
  2. 2.
    Socié G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341:14–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Socié G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101:3373–3385.CrossRefGoogle Scholar
  4. 4.
    Vogelsang GB. How I treat chronic graft-versus-host disease. Blood. 2001;97:1196–1201.CrossRefPubMedGoogle Scholar
  5. 5.
    Lee SJ, Vogelsang GB, Flowers MED. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9:215–233.CrossRefGoogle Scholar
  6. 6.
    Mielcarek M, Martin PJ, Leisenring W, et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood. 2003;102:756–762.CrossRefGoogle Scholar
  7. 7.
    Janin-Mercier A, Devergie A, Arrago JP, et al. Systemic evaluation of Sjögren-like syndrome after bone marrow transplantation in man. Transplantation. 1987;43:677–679.CrossRefGoogle Scholar
  8. 8.
    Sullivan KM, Agura E, Anasetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28:250–259.Google Scholar
  9. 9.
    Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versushost syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204–217.CrossRefGoogle Scholar
  10. 10.
    Akpek G, Zahurak ML, Piantadosi S, et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood. 2001;97:1219–1226.CrossRefPubMedGoogle Scholar
  11. 11.
    Akpek G, Lee SJ, Flowers ME, et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood. 2003;102:802–809.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2004

Authors and Affiliations

  1. 1.Service d’Hématologie/Greffe de MoelleHôpital Saint LouisParis CEDEX 10France

Personalised recommendations